THERESA RACHEK: Open Payments
NPI 1750445854 · HYANNIS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 26 payments from 8 companies in 2025. Trend: 2023 $177 · 2024 $317 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $282 |
| Novo Nordisk Inc | 4 | $99 |
| PFIZER INC. | 5 | $96 |
| Lilly USA, LLC | 3 | $80 |
| Phathom Pharmaceuticals, Inc. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| RGH Enterprises LLC | 1 | $26 |
| Lucid Diagnostics Inc. | 1 | $19 |
Products named: AIRSUPRA, MOUNJARO, PAXLOVID, Wegovy, BREZTRI, VOQUEZNA, LEQVIO, PREVNAR 20.
Industry payments across MA — which companies pay providers there.
